Politics Lobbying world
Americans Overwhelmingly Back Funding Home Care for the Elderly. Will It Survive in Democrats' Spending Bill?
With moderate Democrats threatening to tank the White House's sweeping, $3.5 trillion economic package, President Joe Biden's long-standing promise to support older and disabled Americans…On the topic of health care alone, Democratic lawmakers’ priorities are split. House Speaker Nancy Pelosi, who was key to passing the original Affordable Care Act, has focused on strengthening that legislation by permanently making health care premiums cheaper. Sen. Bernie Sanders and other progressives, meanwhile, are adamant that Congress add dental, vision and hearing coverage to Medicare.
The Credit Union National Association hired Jason Stverak as deputy chief advocacy officer for federal government affairs. Stverak most recently served as deputy chief of staff to Sen. Kevin Cramer (R-N.D.) and previously led the Franklin Center for Government and Public Integrity.
Apple Inc. hired April Jones as a senior government affairs policy counsel. Jones previously served as legislative director for Sen. Amy Klobuchar (D-Minn.), a senior member of the Senate Commerce Committee.
Courtney Taylor joined ML Strategies as senior vice president. Taylor most recently was a partner at public policy firm Mindset. She previously was policy director at the Environmental Defense Fund and served as an attorney for the Justice Department and Department of the Interior.
Joe Biden's HHS Secretary Has the Power to Lower Drug Prices. He Isn't Using It
Xavier Becerra pushed Trump to limit pharmaceutical price gouging. Now he's the one refusing to act.Much of the ongoing political debate about lowering the country's exorbitant drug prices has focused on whether Congress will authorize Medicare to use its purchasing power to negotiate more reasonable pharmaceutical prices. In the meantime, though, Becerra's office has the power to license patented pharmaceutical products made with federal funding. In July, lawmakers sent a letter to Becerra's office calling on the secretary to examine making use of these so-called "march-in" rights to control drug pricing.
Jen Farber joined Firehouse Strategies as managing director. Farber previously led advocacy campaigns at communication firms Purple Strategies and GMMB and was a staffer for former President Barack Obama's 2008 campaign.
Pyxis Partners hired Jason Wallace as a director. Wallace most recently served in Washington, D.C., Mayor Muriel Bowser's (D) cabinet and previously served as an advance associate under former President Obama.
Alyssa Marois joined HSBC Bank USA as senior vice president of public affairs. Marois most recently was vice president of federal government relations at JPMorgan and previously served as legislative director for then-Rep. Kyrsten Sinema (D-Ariz.).
Van Heuvelen Strategies is joining The Vogel Group. Bob Van Heuvelen, the firm's founder and CEO, will be a principal. Van Heuvelen previously served as chief of staff to former Sen. Kent Conrad (D-N.D.).
Ban on negotiating Medicare drug prices under pressure .
WASHINGTON (AP) — Donna Weiner looks at Medicare’s prescription drug program from two different points of view. As a participant, she wants to pay less for her medicines, which cost her about $6,000 a year. As a retired accountant who spent 50 years handling the books for companies, she sees a way to get there. “You know from working in a business that it makes no sense for an administrator of a plan or a company not to be involved in what they have to pay out,” said Weiner, who lives near Orlando, Florida. For Medicare “to negotiate those prices down would be thousands of dollars back in my pocket every year,” she said.